China's phase 2 trial finds COVID-19 vaccine safe, inducing immune response -- The Lancet

Special: Battle Against Novel Coronavirus

A phase 2 trial of a COVID-19 vaccine candidate in China has found that the vaccine is safe and induces an immune response, according to a new study published Monday in medical journal The Lancet.